Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Katsiki, N., Koumaras C., Athyros V. G., & Karagiannis A. (2012).  Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk.. Angiology. 63(1), 9-11.
Katsiki, N., MSc V. Kolovou, PhD A. Tsipis Md, PhD C. Mihas Md, Md V. Vartela, PhD M. Koutelou M., et al. (2018).  Gene Polymorphisms in Cardiovascular Disease and Cancer.. Angiology. 69(8), 738-739.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2015).  Nicotinic Acid and new-onset diabetes.. Horm Metab Res. 47(7), 544-5.
Katsiki, N., Tziomalos K., Chatzizisis Y., Elisaf M., & Hatzitolios A. I. (2010).  Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?. Atherosclerosis. 211(1), 9-14.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome.. Expert Opin Pharmacother. 13(2), 287-8; author reply 289-90.
Katsiki, N., Doumas M., & Mikhailidis D. P. (2016).  Lipids, Statins and Heart Failure: An Update.. Curr Pharm Des. 22(31), 4796-4806.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Vitamin D deficiency, statin-related myopathy and other links with vascular risk.. Curr Med Res Opin. 27(9), 1691-2.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and Type 2 Diabetes Mellitus: An Update After 1 Year.. Curr Pharm Des. 22(18), 2723-5.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Metabolic syndrome and non-cardiac vascular diseases: an update from human studies.. Curr Pharm Des. 20(31), 4944-52.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study.. Clin Appl Thromb Hemost. 18(1), 113-4.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Reaching hypertriglyceridemia goals.. Curr Med Res Opin. 30(3), 391-3.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial.. J Hepatol. 57(2), 476.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.. Curr Vasc Pharmacol. 12(4), 627-41.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.. J Clin Lipidol. 6(1), 93.
Katsiki, N., Athyros V. G., & Karagiannis A. (2014).  Achieving lipid targets in primary care settings.. Curr Med Res Opin. 30(10), 1971-4.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.. Int Angiol. 30(3), 295; author reply 296.
Katsiki, N., Athyros V. G., Karagiannis A., Wierzbicki A. S., & Mikhailidis D. P. (2014).  Should we expand the concept of coronary heart disease equivalents?. Curr Opin Cardiol. 29(4), 389-95.
Katsiki, N., Athyros V. G., & Mikhailidis D. P. (2010).  New developments in the treatment and prevention of vascular disease--part 1.. Curr Pharm Des. 16(34), 3767-9.
Katsiki, N., Hatzitolios A. I., & Mikhailidis D. P. (2011).  Passive smoking: the democratic right of nonsmokers to survive.. Angiology. 62(7), 520-2.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  High-density lipoprotein, vascular risk, cancer and infection: a case of quantity and quality?. Curr Med Chem. 21(25), 2917-26.
Katsiki, N., Georgiadou E., & Hatzitolios A. I. (2009).  The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.. Drugs. 69(11), 1417-31.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2014).  Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit.. Expert Rev Cardiovasc Ther. 12(3), 295-6.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Current treatment for nonalcoholic fatty liver disease.. Expert Opin Pharmacother. 12(13), 2141-2; author reply 2142.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  The role of statins in the treatment of type 2 diabetes mellitus: an update.. Curr Pharm Des. 20(22), 3665-74.
Katsiki, N., Yovos J. G., Gotzamani-Psarrakou A., & Karamitsos D. T. (2011).  Adipokines and vascular risk in type 2 diabetes mellitus.. Angiology. 62(8), 601-4.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές